EP4508069A1 — Ribosomal engagement potency assay
Assigned to ModernaTx Inc · Expires 2025-02-19 · 1y expired
What this patent protects
Provided herein are methods for detecting and/or measuring mRNA associated with ribosomes in a cell. The method can be used to assess potency and other characteristics of an mRNA drug product. Also provided are related products, including cells and reagents.
USPTO Abstract
Provided herein are methods for detecting and/or measuring mRNA associated with ribosomes in a cell. The method can be used to assess potency and other characteristics of an mRNA drug product. Also provided are related products, including cells and reagents.
Drugs covered by this patent
- Onpattro (PATISIRAN SODIUM) · Alnylam Pharmaceuticals
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.